---
title: "SL Science Holding Limited (SLBT.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SLBT.US.md"
symbol: "SLBT.US"
name: "SL Science Holding Limited"
industry: "Asset Management and Custody Banks"
datetime: "2026-06-16T13:06:44.910Z"
locales:
  - [en](https://longbridge.com/en/quote/SLBT.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SLBT.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SLBT.US.md)
---

# SL Science Holding Limited (SLBT.US)

## Company Overview

SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company’s products include SL bio’s milk-derived exosome essence, SL bio’s tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. The company was formerly known as SL BIO Co., Ltd.

| Item | Detail |
|------|--------|
| Industry | Asset Management and Custody Banks |
| Exchange | US Market |
| Website | [www.sl-bio.com](https://www.sl-bio.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/SLBT.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/SLBT.US/norm.md)
- [Related News](https://longbridge.com/en/quote/SLBT.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/SLBT.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**